Comprehensive Impact of Mounjaro on Diabetes and Obesity in Dubai’s Healthcare Landscape
In recent years, Mounjaro dubai has made waves in Dubai’s healthcare sector, introducing a promising solution for managing Type 2 diabetes and obesity—two of the region’s most prevalent health issues. Developed by Eli Lilly, Mounjaro, or Tirzepatide, is an injectable medication targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, offering dual action […]